Scleroderma News and Research

RSS
Scleroderma is a chronic, often progressive, autoimmune disease in which the body's immune system attacks its own body. The disease, which literally means "hard skin," can cause a thickening and tightening of the skin. In some cases it causes serious damage to internal organs including the lungs, heart, kidneys, esophagus and gastrointestinal tract. Some medicines and treatments can help with certain symptoms, but there is still no cure for scleroderma, which affects about 300,000 nationwide. (By way of comparison, about 50,000 people have muscular dystrophy, 250,000 are estimated to have lupus and 350,000 have multiple sclerosis.)
Pulmonary hypertension may be caused by molecular pathway that damages blood vessels

Pulmonary hypertension may be caused by molecular pathway that damages blood vessels

FDA approves Galderma's Mirvaso topical gel for facial erythema of rosacea

FDA approves Galderma's Mirvaso topical gel for facial erythema of rosacea

Finding avoids needless exposure to potentially toxic treatment

Finding avoids needless exposure to potentially toxic treatment

CPF and PFF to partner with ATS to fund pulmonary fibrosis research

CPF and PFF to partner with ATS to fund pulmonary fibrosis research

Small numbers of ANA- and RP-negative patients with systemic sclerosis

Small numbers of ANA- and RP-negative patients with systemic sclerosis

Scientists uncover new role for TLR4 in development of tissue fibrosis or scarring

Scientists uncover new role for TLR4 in development of tissue fibrosis or scarring

Jefferson researchers to investigate mechanisms involved in nephrogenic systemic fibrosis

Jefferson researchers to investigate mechanisms involved in nephrogenic systemic fibrosis

Computed tomography aids scleroderma lung disease prognosis

Computed tomography aids scleroderma lung disease prognosis

New treatment target brings hope for scleroderma patients

New treatment target brings hope for scleroderma patients

Coalition for Pulmonary Fibrosis announces winners of 2012 annual awards for distinguished service

Coalition for Pulmonary Fibrosis announces winners of 2012 annual awards for distinguished service

CPF to kick off 'Pulmonary Fibrosis Awareness Month'

CPF to kick off 'Pulmonary Fibrosis Awareness Month'

NCI awards Soligenix $300,000 SBIR grant for orBec Phase 2 chronic GI GVHD trial

NCI awards Soligenix $300,000 SBIR grant for orBec Phase 2 chronic GI GVHD trial

MedQIA develops new software that forms the basis of Imaging Biomarker Information System

MedQIA develops new software that forms the basis of Imaging Biomarker Information System

State Senator honors UCLA lung transplant doctors during special ceremony

State Senator honors UCLA lung transplant doctors during special ceremony

Cystic fibrosis patient receives generous 'gift of life'

Cystic fibrosis patient receives generous 'gift of life'

Novo Nordisk, BRI collaborate to speed-up translational research of autoimmune diseases

Novo Nordisk, BRI collaborate to speed-up translational research of autoimmune diseases

Initial HSCT results from phase III trial on systemic sclerosis

Initial HSCT results from phase III trial on systemic sclerosis

Researchers identify new peptide that can block fibrosis of the skin and lungs

Researchers identify new peptide that can block fibrosis of the skin and lungs

African-Americans with scleroderma have more antibodies linked to severe complications

African-Americans with scleroderma have more antibodies linked to severe complications

African Americans have more severe complications from scleroderma

African Americans have more severe complications from scleroderma